Recombinant Human IL21 Protein，His

Interleukin-21 (IL-21) is a key cytokine that plays a critical role in regulating immune responses and maintaining homeostasis within the immune system. It is primarily produced by T cells, particularly follicular helper T cells, and has been shown to influence the function and development of various immune cell types, including B cells, natural killer (NK) cells, and T cells. The significance of IL-21 in immune modulation highlights its potential as a target for therapeutic interventions in various diseases, including autoimmune disorders, cancer, and infectious diseases. Research has demonstrated that recombinant IL-21 proteins can enhance B cell differentiation and antibody production, boost T cell responses, and improve the efficacy of cancer immunotherapies. Moreover, IL-21's ability to combat chronic viral infections adds to its therapeutic appeal. The production of recombinant IL-21 involves sophisticated biotechnological methods, ensuring high purity and bioactivity, which are essential for preclinical and clinical studies. Understanding the structure-function relationship of IL-21 and its signaling pathways is crucial for optimizing its use in therapeutic contexts. Hence, ongoing research into the recombinant expression of IL-21 aims to elucidate its biological functions further, develop novel applications in immunotherapy, and explore its potential to mitigate immune-related diseases.